Table 2 from TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden–High Tumors
收藏Figshare2026-03-16 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_2_from_TAPISTRY_A_Phase_II_Study_of_Atezolizumab_in_Patients_with_Tumor_Mutational_Burden_High_Tumors/31744548
下载链接
链接失效反馈官方服务：
资源简介：
IRC-assessed endpoints per RECIST v1.1 according to NGS assay type in patients with TMB ≥13 and ≥16 mut/Mb.
创建时间：
2026-03-16
